From: Interrelation between cardiac and brain small-vessel disease: a pilot quantitative PET and MRI study
Characteristics | All N = 370 | Patients with normal perfusion N = 176 | Patients with cardiac SVD N = 38 | Patients with obstructive CAD N = 156 |
---|---|---|---|---|
Age (years) | 66 [60–73] | 64 [57–71] | 68 [57–71] | 69 [63–76] |
Sex female/male | 115/255 | 71/105 | 16/22 | 28/128 |
Weight (kg) | 79.5 [68–90] | 78 [66–90] | 78 [71–89] | 81 [70–90] |
Body mass index (kg/m2) | 27.2 [23.8–31.2] | 26.7 [23.5–30.4] | 26.9 [23.0–32.7] | 27.8 [24.5–31.9] |
Cardiovascular risk factors | ||||
Smoking | 94/370 | 44/176 | 11/38 | 39/156 |
Hypertension | 274/370 | 121/176 | 28/38 | 125/156 |
Diabetes | 145/370 | 60/176 | 20/38 | 65/156 |
Dyslipidemia | 233/370 | 101/176 | 26/38 | 106/156 |
Other comorbidities | ||||
Obstructive sleep apnea syndrome | 67/370 | 35/176 | 5/38 | 27/156 |
Lower extremity arterial disease | 62/370 | 21/176 | 6/38 | 35/156 |
Treatments | ||||
Platelet antiaggregants | 250/370 | 100/176 | 22/38 | 128/156 |
Beta-blockers | 210/370 | 83/176 | 23/38 | 104/156 |
ACE inhibitors | 208/370 | 82/176 | 17/38 | 109/156 |
Diuretic | 156/370 | 56/176 | 21/38 | 79/156 |
Nitroglycerin | 44/370 | 15/176 | 3/38 | 26/156 |
Lipids lowering agents | 228/370 | 92/176 | 15/38 | 121/156 |